Pharmaceutical Manufacturing of Topical Spray (BenzoCaine & Menthol)

This contract involves the subcontracted manufacturing of a topical anesthetic spray containing benzocaine and menthol. The production must adhere to stringent regulatory requirements, including FDA current Good Manufacturing Practices (cGMP), National Drug Code (NDC) registration, and Department of Defense medical standards, ensuring a high level of quality and compliance suitable for defense-related medical supply needs. The work is to be performed at Fort Bragg, with the contract issued by the Medical Supply Chain Pharmacy Field Support Activity under the Department of Defense. The solicitation was posted on May 27, 2026, with a response deadline on June 2, 2026, indicating a short turnaround for proposals. The contract falls under the NAICS code 325412, which covers pharmaceutical manufacturing, emphasizing its industrial and regulated nature. This subcontract does not specify any set-aside status or particular organization type requirements, focusing primarily on meeting the technical and compliance standards for producing the anesthetic spray in a controlled environment.